Effect of oral clodronate on structural damage and bone turnover in rheumatoid arthritis.
Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland. [email protected]
- Published Article
Clinical and experimental rheumatology
- Publication Date
Jan 01, 2012
Oral clodronate did not retard the focal bone damage in RA despite its beneficial effect on overall bone metabolism, as judged by the decrease in the reference bone biomarkers.
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 01/12/2018 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/22260818